Climb Global Solutions (CLMB) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting will be held virtually on June 3, 2025, with voting and Q&A available online for shareholders with a control number.
Shareholders will vote on the election of five directors, executive compensation, frequency of say-on-pay votes, and ratification of the external auditor.
The Board recommends voting for all director nominees and all proposals on the agenda.
Proxy materials and the 2024 Annual Report are available online for review.
Voting matters and shareholder proposals
Proposals include: election of five directors, advisory vote on executive compensation, advisory vote on frequency of say-on-pay, and ratification of Deloitte as auditor.
Board recommends annual say-on-pay votes and supports all proposals.
Shareholders can submit proposals for the 2026 meeting by December 30, 2025.
Board of directors and corporate governance
Board consists of five members, four of whom are independent; CEO and Chair roles are separated.
Board committees: Audit, Compensation, and Nominating & Corporate Governance; all committees are fully independent.
Board met ten times in 2024; all directors attended at least 75% of meetings.
Board leadership structure emphasizes independent oversight and regular executive sessions.
Director nominations consider experience, diversity, and independence; stockholders may submit nominees.
Latest events from Climb Global Solutions
- Record 2025 sales and income growth; dividend suspended to fund expansion and acquisitions.CLMB
Q4 202526 Feb 2026 - Q2 net income more than doubled, DSS acquisition boosts EdTech, and ERP drives efficiency.CLMB
Q2 20242 Feb 2026 - Q3 net sales rose 52% and net income more than doubled, fueled by organic and acquisition growth.CLMB
Q3 202417 Jan 2026 - Record 2024 results with 51% net income growth and strong security segment performance.CLMB
Q4 202426 Dec 2025 - Q1 2025 net sales up 49%, net income up 35%, and adjusted EBITDA at $7.6 million.CLMB
Q1 202524 Dec 2025 - Q2 2025 net sales and income rose over 70%, led by organic growth and DSS acquisition.CLMB
Q2 202516 Nov 2025 - Net sales up 35% to $161.3M, with strong cash growth and a $0.17 dividend declared.CLMB
Q3 20255 Nov 2025 - Q1 2025 gross billings surged 34% as focus on emerging tech and acquisitions drove strong growth.CLMB
Investor Presentation25 Jun 2025